These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 32573325)

  • 1. Utilization and Complications of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy.
    Rozen G; Elbaz-Greener G; Marai I; Andria N; Hosseini SM; Biton Y; Heist EK; Ruskin JN; Gavrilov Y; Carasso S; Ghanim D; Amir O
    J Am Heart Assoc; 2020 Jul; 9(13):e015721. PubMed ID: 32573325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of catheter ablation for atrial fibrillation in the octogenarian population.
    Romero J; Ogunbayo G; Elayi SC; Darrat Y; Rios SA; Diaz JC; Alviz I; Cerna L; Gabr M; Chernobelsky E; Mohanty S; Trivedi CG; Della Rocca DG; Natale A; Di Biase L
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2686-2693. PubMed ID: 31506996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal trends of in-hospital complications associated with catheter ablation of atrial fibrillation in the United States: An update from Nationwide Inpatient Sample database (2011-2014).
    Tripathi B; Arora S; Kumar V; Abdelrahman M; Lahewala S; Dave M; Shah M; Tan B; Savani S; Badheka A; Gopalan R; Shantha GPS; Viles-Gonzalez J; Deshmukh A
    J Cardiovasc Electrophysiol; 2018 May; 29(5):715-724. PubMed ID: 29478273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy patients: a systematic review.
    Ha HS; Wang N; Wong S; Phan S; Liao J; Kumar N; Qian P; Yan TD; Phan K
    J Interv Card Electrophysiol; 2015 Nov; 44(2):161-70. PubMed ID: 26302740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedural Patterns and Safety of Atrial Fibrillation Ablation: Findings From Get With The Guidelines-Atrial Fibrillation.
    Loring Z; Holmes DN; Matsouaka RA; Curtis AB; Day JD; Desai N; Ellenbogen KA; Feld GK; Fonarow GC; Frankel DS; Hurwitz JL; Knight BP; Joglar JA; Russo AM; Sidhu MS; Turakhia MP; Lewis WR; Piccini JP
    Circ Arrhythm Electrophysiol; 2020 Sep; 13(9):e007944. PubMed ID: 32703018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis.
    Providencia R; Elliott P; Patel K; McCready J; Babu G; Srinivasan N; Bronis K; Papageorgiou N; Chow A; Rowland E; Lowe M; Segal OR; Lambiase PD
    Heart; 2016 Oct; 102(19):1533-43. PubMed ID: 27234160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of nonpharmacologic treatment of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Bassiouny M; Lindsay BD; Lever H; Saliba W; Klein A; Banna M; Abraham J; Shao M; Rickard J; Kanj M; Tchou P; Dresing T; Baranowski B; Bhargava M; Callahan T; Tarakji K; Cantillon D; Hussein A; Marc Gillinov A; Smedira NG; Wazni O
    Heart Rhythm; 2015 Jul; 12(7):1438-47. PubMed ID: 25814420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends and predictors of early ablation for Atrial Fibrillation in a Nationwide population under age 65: a retrospective observational study.
    D'Angelo RN; Khanna R; Yeh RW; Goldstein L; Kalsekar I; Marcello S; Tung P; Zimetbaum PJ
    BMC Cardiovasc Disord; 2020 Apr; 20(1):161. PubMed ID: 32252637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures.
    Deshmukh A; Patel NJ; Pant S; Shah N; Chothani A; Mehta K; Grover P; Singh V; Vallurupalli S; Savani GT; Badheka A; Tuliani T; Dabhadkar K; Dibu G; Reddy YM; Sewani A; Kowalski M; Mitrani R; Paydak H; Viles-Gonzalez JF
    Circulation; 2013 Nov; 128(19):2104-12. PubMed ID: 24061087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and procedural predictors of early complications of ablation for atrial fibrillation: analysis of the national registry data.
    Inoue K; Murakawa Y; Nogami A; Shoda M; Naito S; Kumagai K; Miyauchi Y; Yamane T; Morita N; Okumura K;
    Heart Rhythm; 2014 Dec; 11(12):2247-53. PubMed ID: 25131666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term clinical course after catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Higuchi S; Ejima K; Minami Y; Ooyabu K; Iwanami Y; Yagishita D; Shoda M; Hagiwara N
    Heart Vessels; 2019 Mar; 34(3):527-537. PubMed ID: 30255478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Zheng S; Jiang W; Dai J; Li K; Shi H; Wu W; Liu X; He B; Qiu X; Song Z
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):621-628. PubMed ID: 31930545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes and Predictors of Readmission in Patients With Atrial Fibrillation Undergoing Catheter Ablation: A National Population-Based Cohort Study.
    Arora S; Lahewala S; Tripathi B; Mehta V; Kumar V; Chandramohan D; Lemor A; Dave M; Patel N; Patel NV; Palamaner Subash Shantha G; Viles-Gonzalez J; Deshmukh A
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29907655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Hausvater A; Link MS; Abt P; Gionfriddo W; Wang W; Rastegar H; Estes NAM; Maron MS; Maron BJ
    Circulation; 2017 Dec; 136(25):2420-2436. PubMed ID: 28916640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does ablation of atrial fibrillation at the time of septal myectomy improve survival of patients with obstructive hypertrophic cardiomyopathy?
    Cui H; Schaff HV; Dearani JA; Lahr BD; Viehman JK; Geske JB; Nishimura RA; Ommen SR
    J Thorac Cardiovasc Surg; 2021 Mar; 161(3):997-1006.e3. PubMed ID: 32977972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Mortality Following Catheter Ablation of Atrial Fibrillation.
    Cheng EP; Liu CF; Yeo I; Markowitz SM; Thomas G; Ip JE; Kim LK; Lerman BB; Cheung JW
    J Am Coll Cardiol; 2019 Nov; 74(18):2254-2264. PubMed ID: 31672181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: a European observational multicentre study.
    Creta A; Elliott P; Earley MJ; Dhinoja M; Finlay M; Sporton S; Chow A; Hunter RJ; Papageorgiou N; Lowe M; Mohiddin SA; Boveda S; Adragao P; Jebberi Z; Matos D; Schilling RJ; Lambiase PD; Providência R
    Europace; 2021 Sep; 23(9):1409-1417. PubMed ID: 33930121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial Fibrillation in Heart Failure US Ambulatory Cardiology Practices and the Potential for Uptake of Catheter Ablation: An National Cardiovascular Data Registry (NCDR
    Mathew JS; Marzec LN; Kennedy KF; Jones PG; Varosy PD; Masoudi FA; Maddox TM; Allen LA
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catheter ablation of atrial fibrillation in patients with and without hypertrophic cardiomyopathy: systematic review and meta-analysis.
    Ezzeddine FM; Agboola KM; Hassett LC; Killu AM; Del-Carpio Munoz F; DeSimone CV; Kowlgi GN; Deshmukh AJ; Siontis KC
    Europace; 2023 Aug; 25(9):. PubMed ID: 37595138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Outcome of Catheter Ablation for Atrial Fibrillation in Patients With Apical Hypertrophic Cardiomyopathy.
    Roh SY; Kim DH; Ahn J; Lee KN; Lee DI; Shim J; Choi JI; Park SW; Kim YH
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):788-95. PubMed ID: 27062657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.